Large non-coding RNAs and microRNAs are important regulators of gene expression that may control both physiological and pathological processes such as neurodegenerative disorders. Given the complexity of neurodegenerative disorder...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SAF2011-26211
EL OTRO LADO DEL GENOMA: CUANDO LA REGION NO CODIFICANTE ES...
157K€
Cerrado
SAF2014-60551-R
IDENTIFICACION DE RNAS NO CODIFICANTES (SNCRNAS) IMPLICADOS...
169K€
Cerrado
LNCRNADROCNS
Long Non coding RNAs with specific regulation and function i...
162K€
Cerrado
RIBOMYLOME
The Role of Non coding RNA in Protein Networks and Neurodege...
1M€
Cerrado
lincSAFARI
Sequence and Function Relationships in Long Intervening Nonc...
2M€
Cerrado
NOJUNKDNA
A strategy to investigate cell type specific effects of non...
171K€
Cerrado
Información proyecto NCRNANEURO
Líder del proyecto
VIB VZW
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
215K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Large non-coding RNAs and microRNAs are important regulators of gene expression that may control both physiological and pathological processes such as neurodegenerative disorders. Given the complexity of neurodegenerative disorders, studying the role of non-coding RNAs would be necessary to understand the molecular mechanisms underlying ageing related neurodegeneration. Of particular interest, microRNAs (miRNAs) seem to participate directly in the regulation of Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) related genes. In this regard, microRNA research would be promising for the understanding of the very prevalent and poorly understood sporadic forms of AD and possibly PD. To address the role of specific microRNAs in biological models, the project will consist in determining whether down-regulation of specific microRNAs in zebrafish and mouse models recapitulate neurodegeneration. The identification of mRNA targets of such microRNAs will provide insight into the cellular pathways that are disturbed after microRNA knock-down. To complement the study on microRNAs, another objective of the project will be to determine whether large non-coding RNAs are dysregulated in neurodegenerative diseases similar to what is observed for microRNAs. The study of non-coding RNAs will provide a novel layer of complexity in neuronal cell biology and be exciting tools to probe and discover molecular mechanisms underlying neurodegeneration.